GlassScriptPhysician profile
Kyle J Kinmon
NPI 1023076312
$29,924.14
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $263 · 2021: $600 · 2022: $293 · 2023: $182 · 2024: $70.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $252.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flower Orthopedics Coporation | $27,662.47 | 2019-2021 | |
| Djo, LLC | $593.98 | 2019-2023 | Cmf |
| Abbott Laboratories | $348.80 | 2019-2020 | |
| Stryker Corporation | $323.39 | 2019-2023 | Anchorage |
| Boston Scientific Corporation | $178.11 | 2019-2024 | Varithena Administration Pack |
| Acera Surgical, INC. | $133.60 | 2022 | |
| Smith+Nephew, INC. | $131.09 | 2020-2022 | |
| Horizon Therapeutics Plc | $114.05 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $109.51 | 2019 | |
| Stimwave Technologies Incorporated | $95.31 | 2021 | |
| Integra Lifesciences Corporation | $63.06 | 2019 | |
| Ossio INC | $50.00 | 2022 | |
| Bard Peripheral Vascular, INC. | $46.21 | 2024 | Venclose Maven Catheter |
| Zimvie INC. | $21.73 | 2023 | |
| Wright Medical Technology, INC. | $16.90 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $13.45 | 2021 | |
| Allergan, INC. | $11.47 | 2019 | |
| Bioventus LLC | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Kinmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.